92 related articles for article (PubMed ID: 24361088)
1. Correlation of genotype, phenotype, and mRNA expression of CYP2D6 and CYP2C19 in peripheral blood leukocytes (PBLs).
Kuhlmann JB; Wensing G; Kuhlmann J
Int J Clin Pharmacol Ther; 2014 Feb; 52(2):143-50. PubMed ID: 24361088
[TBL] [Abstract][Full Text] [Related]
2. Cytochrome P450 2C19 enzyme, Cytochrome P450 2C9 enzyme, and Cytochrome P450 2D6 enzyme allelic variants and its possible effect on drug metabolism: A retrospective study.
Naujokaitis D; Asmoniene V; Kadusevicius E
Medicine (Baltimore); 2021 Mar; 100(11):e24545. PubMed ID: 33725937
[TBL] [Abstract][Full Text] [Related]
3. Applications of CYP450 testing in the clinical setting.
Samer CF; Lorenzini KI; Rollason V; Daali Y; Desmeules JA
Mol Diagn Ther; 2013 Jun; 17(3):165-84. PubMed ID: 23588782
[TBL] [Abstract][Full Text] [Related]
4. Frequencies of
Scherf-Clavel M; Weber H; Unterecker S; Müller DJ; Deckert J
World J Biol Psychiatry; 2024 Apr; 25(4):214-221. PubMed ID: 38493365
[TBL] [Abstract][Full Text] [Related]
5. Investigation of the Differences in the Pharmacokinetics of CYP2D6 Substrates, Desipramine, and Dextromethorphan in Healthy African Subjects Carrying the Allelic Variants CYP2D6*17 and CYP2D6*29, When Compared with Normal Metabolizers.
Marasanapalle VP; Masimirembwa C; Sivasubramanian R; Sayyed S; Weinzierl-Hinum A; Mehta D; Kapungu NN; Kanji C; Thelingwani R; Zack J
J Clin Pharmacol; 2024 May; 64(5):578-589. PubMed ID: 37803948
[TBL] [Abstract][Full Text] [Related]
6. Effect of CYP2D6 and CYP2C19 genotypes on atomoxetine serum levels: A study based on therapeutic drug monitoring data.
Smith RL; Molden E; Bernard JP
Br J Clin Pharmacol; 2023 Jul; 89(7):2246-2253. PubMed ID: 36851891
[TBL] [Abstract][Full Text] [Related]
7. Effects of Maribavir on P-Glycoprotein and CYP2D6 in Healthy Volunteers.
Song IH; Ilic K; Murphy J; Lasseter K; Martin P
J Clin Pharmacol; 2020 Jan; 60(1):96-106. PubMed ID: 31385617
[TBL] [Abstract][Full Text] [Related]
8. Influence of
Islam F; Magarbeh L; Elsheikh SSM; Kloiber S; Espinola CW; Bhat V; Frey BN; Milev R; Soares CN; Parikh SV; Placenza F; Hassel S; Taylor VH; Leri F; Blier P; Uher R; Farzan F; Lam RW; Turecki G; Foster JA; Rotzinger S; Kennedy SH; Müller DJ
Can J Psychiatry; 2024 Mar; 69(3):183-195. PubMed ID: 37796764
[TBL] [Abstract][Full Text] [Related]
9. Xenobiotic sensor- and metabolism-related gene variants in environmental sensitivity-related illnesses: a survey on the Italian population.
Caccamo D; Cesareo E; Mariani S; Raskovic D; Ientile R; Currò M; Korkina L; De Luca C
Oxid Med Cell Longev; 2013; 2013():831969. PubMed ID: 23936614
[TBL] [Abstract][Full Text] [Related]
10. Pharmacogenomic testing for CYP2C19 and CYP2D6 in cyclic vomiting syndrome.
Patel M; Partovi O; Karrento K; Garacchi Z; Balasubramanian G; Venkatesan T
Neurogastroenterol Motil; 2024 Jan; 36(1):e14705. PubMed ID: 37953495
[TBL] [Abstract][Full Text] [Related]
11. Effect of CYP2D6 genotype on duloxetine serum concentration.
Hole K; Gangsø S; Jensstuen ÅT; Ormøy HH; Paulsen M; Molden E; Haslemo T
Basic Clin Pharmacol Toxicol; 2024 Jan; 134(1):186-192. PubMed ID: 37864290
[TBL] [Abstract][Full Text] [Related]
12. Effect of isotretinoin on CYP2D6 and CYP3A activity in patients with severe acne.
Zhao Y; Vary JC; Yadav AS; Czuba LC; Shum S; LaFrance J; Huang W; Isoherranen N; Hebert MF
Br J Clin Pharmacol; 2024 Mar; 90(3):759-768. PubMed ID: 37864393
[TBL] [Abstract][Full Text] [Related]
13. Age of onset for increased dose-adjusted serum concentrations of antidepressants and association with sex and genotype: An observational study of 34,777 individuals.
Tveit K; Hermann M; Nilsen RM; Wallerstedt SM; Rongve A; Molden E; Hole K
Eur J Clin Pharmacol; 2024 Mar; 80(3):435-444. PubMed ID: 38197945
[TBL] [Abstract][Full Text] [Related]
14. CYP2D6 Activity Is Correlated with Changes in Plasma Concentrations of Taurocholic Acid during Pregnancy and Postpartum in CYP2D6 Extensive Metabolizers.
Czuba LC; Malhotra K; Enthoven L; Fay EE; Moreni SL; Mao J; Shi Y; Huang W; Totah RA; Isoherranen N; Hebert MF
Drug Metab Dispos; 2023 Nov; 51(11):1474-1482. PubMed ID: 37550070
[TBL] [Abstract][Full Text] [Related]
15. Meta-analysis of CYP2C19 and CYP2D6 metabolic activity on antidepressant response from 13 clinical studies using genotype imputation.
Li D; Pain O; Fabbri C; Wong WLE; Lo CWH; Ripke S; Cattaneo A; Souery D; Dernovsek MZ; Henigsberg N; Hauser J; Lewis G; Mors O; Perroud N; Rietschel M; Uher R; Maier W; Baune BT; Biernacka JM; Bondolfi G; Domschke K; Kato M; Liu YL; Serretti A; Tsai SJ; Weinshilboum R; ; ; McIntosh AM; Lewis CM
medRxiv; 2023 Dec; ():. PubMed ID: 37425775
[TBL] [Abstract][Full Text] [Related]
16. Impact of Pregnancy and Vitamin A Supplementation on CYP2D6 Activity.
Amaeze OU; Czuba LC; Yadav AS; Fay EE; LaFrance J; Shum S; Moreni SL; Mao J; Huang W; Isoherranen N; Hebert MF
J Clin Pharmacol; 2023 Mar; 63(3):363-372. PubMed ID: 36309846
[TBL] [Abstract][Full Text] [Related]
17. CYP2D6 Protein Level Is the Major Contributor to Interindividual Variability in CYP2D6-Mediated Drug Metabolism in Healthy Human Liver Tissue.
Ning M; Duarte JD; Rubin LH; Jeong H
Clin Pharmacol Ther; 2018 Nov; 104(5):974-982. PubMed ID: 29349771
[TBL] [Abstract][Full Text] [Related]
18. Quantification of In Vivo Metabolic Activity of CYP2D6 Genotypes and Alleles Through Population Pharmacokinetic Analysis of Vortioxetine.
Frederiksen T; Areberg J; Schmidt E; Bjerregaard Stage T; Brøsen K
Clin Pharmacol Ther; 2021 Jan; 109(1):150-159. PubMed ID: 32599653
[TBL] [Abstract][Full Text] [Related]
19. Pharmacogenetic testing of CYP2D6, CYP2C19 and CYP2C9 in Denmark: Agreement between publicly funded genotyping tests and the subsequent phenotype classification.
Baltzer Houlind M; Hansen L; Iversen E; Rasmussen HB; Larsen JB; Jørgensen S; Dalhoff K; Damkier P; Walls AB; Vermehren C; Andersen TRH; Kallemose T; Christrup L; Westergaard N
Basic Clin Pharmacol Toxicol; 2024 May; 134(5):756-763. PubMed ID: 38403838
[No Abstract] [Full Text] [Related]
20. Solanidine is a sensitive and specific dietary biomarker for CYP2D6 activity.
Kiiski JI; Neuvonen M; Kurkela M; Hirvensalo P; Hämäläinen K; Tarkiainen EK; Sistonen J; Korhonen M; Khan S; Orpana A; Filppula AM; Lehtonen M; Niemi M
Hum Genomics; 2024 Feb; 18(1):11. PubMed ID: 38303026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
